External Scientific Affairs Oncology Job at Daiichi Sankyo Inc – Edison, New Jersey
Hiring Company Industry: Biotech/Pharma
Number of Employees: 1,000 – 10,000 Employees
Total Compensation: $100K+
Location: Edison, NJ; Mid-Atlantic
Job Summary: We are currently seeking a Director, External Scientific Affairs for our Edison, New Jersey location. This position will lead and support the identification of potential in-licensing and co-development opportunities including development candidate and product licensing, academic and industrial R&D collaborations, external technology relationships and support of M&A opportunities primarily in the area of oncology.Other responsibilities include working closely with External Scientific Affairs colleagues and line management to identify strategic pipeline needs and implementation of an external scientific affairs program to identify in-licensing opportunities academic collaborations aligned with internal strategic needs in coordination with Global R&D Leadership. Responsibilities:In this role, you will identify and establish relationships with potential co-development and in-licensing partners to accelerate the identification of external opportunities and manage the initial scientific assessment evaluation.You will also provide expertise in the scientific assessment, therapeutic evaluation and feasibility for external in-licensing/research alliance opportunities as part of the global scientific assessment with internal stakeholders from U.S. and other business regions; support the internal scientific review and feasibility process once decision is made to pursue at a confidential level; and work in unison with R&D, and Business Development & Licensing to support the evaluation and feasibility analysis team to coordinate full overview of in-licensing/research alliance opportunity and prepare document for submission and presentation to the Licensing Steering Committee. Additionally, you will collaborate with Global Licensing Committee and R&D senior management and the Therapeutic Strategy Committee (TASC) through the Therapeutic Area Licensing Committee (TALC) to ensure complete understanding of the R&D research portfolio and in-licensing needs and develop the TA Opportunity List to support external opportunity identification and evaluation.
Education/Experience
Qualified candidates must have an advanced degree PhD, DVM or MD and post-doctoral training. 5-10 years experience as a research scientist in an academic and/or industry research lab setting directing a research program using in vitro or in vivo techniques to identify novel drug development approaches in the area of oncology. Alternately, 5-10 years of experience in managing clinical research programs evaluating novel cancer treatments with demonstrated expertise in the identification and evaluation of novel oncology therapeutic approaches. Experience working in pharmaceutical and/or biotech setting is preferred. The ideal candidate will also have some experience associated with an external scientific affairs capacity in the pharmaceutical industry and will have led the internal process of managing the scientific/technical review of an internal in-licensing candidate in the area of Oncology.Demonstrates ability to work in a team environment and has leadership competency to take initiative and implement the project from initiation through to transfer to the licensing team.Competency in therapeutic areas of primarily oncology. Scientific knowledge and experience with targeted therapeutics and biologics.A good understanding of the drug discovery and development process, intellectual property, CMC, contracts and negotiating is required. Understanding of regulatory and development standards for US, EU and ROW are desirable.Excellent scientific judgment and analytical skills, creativity, and independent decision-making ability in the area of therapeutic antibodies. With strong involvement in decision making process for Go / No-Go decisions.Excellent interpersonal skills; strong writing skills; cross-functional team experience.
Daiichi Sankyo Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., which is a global pharmaceutical innovator.
The headquarters company was established in 2005 from the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world.
A central focus of Daiichi Sankyo’s research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes and acute coronary syndrome. Also important to the company is the discovery of new medicines in the areas of infectious diseases, cancer, bone and joint diseases, and immune disorders.
External Scientific Affairs Oncology Job at Daiichi Sankyo Inc – Edison, New Jersey